Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 47 items.
Affected lots are missing risk statements on the bottle.
RecallHealth product recall | 2023-09-26
Medicinal Ingredients (active ingredients) on bottle label of affected lot may be illegible.
RecallHealth product recall | 2023-08-29
Affected lots are labelled with incorrect dosage form found on the label.
RecallHealth product recall | 2023-08-24
Linear barcode printed on the vial label is non-functioning.
RecallHealth product recall | 2023-08-21
An incorrect NPN is on the primary space of the affected lot.
RecallHealth product recall | 2023-08-14
Lot number and expiry date on vial label of affected lots may become illegible.
RecallHealth product recall | 2023-08-09
Affected lots are labelled with the incorrect amount of medicinal ingredient.
RecallHealth product recall | 2023-07-27
An incorrect label (Venlafaxine XR 37.5 mg) is attached to some units of the affected lot which contains: Venlafaxine XR 150 mg.
RecallHealth product recall | 2023-06-22
JAMP Pharma Corporation is recalling mislabelled bottles from lot PTC5140A of Venlafaxine extended release (XR) capsules after one bottle labelled to contain 37.5 mg capsules was found to contain 150 mg capsules. Only the mislabelled bottles are being…
AlertPublic advisory | 2023-06-21
Nestlé Health Science is recalling twelve lots of Nature’s Bounty Kids Multivitamin Gummies
(NPN 80117143) because the product’s label does not indicate that the gummies should not be given to children under four years of age. Giving these products to…
AlertPublic advisory | 2023-06-01
Affected lots are incorrectly labelled for use in the subpopulation that is less than 4 years of age.
RecallHealth product recall | 2023-06-01
Affected lots may be missing the DIN and Canadian contact information on the outer label.
RecallHealth product recall | 2023-05-05
Affected lot is missing risk statements on the outer label; Affected lot is labelled with claims that are not compliant with its terms of market authorization; Regulated party does not hold a site licence for sale of the product in Canada.
RecallHealth product recall | 2023-05-05
Affected lots are incorrectly labelled for use in the pediatric subpopulation.
RecallHealth product recall | 2023-02-24
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09